Buy This Stock Profiting from the Oil Supply Glut

Many of my recommendations to The Dividend Hunter subscribers are companies that are very lightly followed by the financial media, if at all. I have found that a very large portion of the individual stock coverage focuses on a very small number of stocks. This applies whether you are looking at blue chip stocks, new […]

Read more

2 Stocks Cashing in on the Largest Gambling Mecca in the World

The growth of gambling on the enclave of Macau over the last decade has been simply been extraordinary to observe. The former Portuguese colony has started from nothing to become the gambling mecca of the world. Its annual gaming revenues easily dwarf those of Las Vegas by multiples. The growth in gambling in Macau has […]

Read more

Buy These Dividend Growth Stocks for 50% Gains

I am sure you’re just as familiar with the current maladies in the energy sector as I am. Share prices are down and nobody knows where oil will be trading tomorrow. But, the future is still clear. America is working its way towards energy independence and these two companies trading at bargain prices are going […]

Read more

2 Breakout Stocks in the Market’s Hottest Sector

To successfully invest in the small-cap biotech sector takes strategy and guts. If you want to reap the rewards you have to be prepared. Bret Jensen has developed a two-part strategy that has led his followers to returns like 120% and 180% in a matter of months, and if you follow along you will see […]

Read more

The End of Google Is Here, Part II

There’s no denying Google’s dominance since its 2004 IPO, but the end of this juggernaut’s growth story is here. Investors looking for life-changing returns must look elsewhere, and the best place for growth is in biotech. New technologies are allowing for more drugs to be synthesized and approved faster than ever, and with a large […]

Read more

4 REITs Raising Dividends in April

The potential of regular dividend increases is one factor that sets REITs apart from many other higher yield types of investments. With the REIT sector acting pretty ugly over the last month or so, an announced dividend increase can be the catalyst to move a share price higher, even in the face of a volatile […]

Read more

2 Refiners That Are a Rare Bright Spot in Energy Sector

It has been a brutal six months for most investors in the energy sector. Thanks to the collapse in crude and weak natural gas prices many sub-sectors of the energy complex have been decimated, and their immediate return seems highly unlikely. Small exploration and producers have largely been crushed and many will file for bankruptcy […]

Read more

Will Rising Interest Rates Tank Your Income Portfolio?

With the Fed about to raise interest rates, the dollar’s record climb, and the oil supply glut, high-yield income investors should be extra cautious right now. Navigating these choppy market conditions is paramount, and Tim Plaehn is recommending two high-yield investments that will help you do just that. They’re on sale right now so don’t […]

Read more

2 Biotech Stocks under $10 to Scoop up Now

Investing in companies that are on the forefront of the biotech revolution is one of the best ways to secure a double or even triple digit return on your investments. These companies are changing the face of medicine, and Bret Jensen, an expert biotech investor, knows which are leading the way. With multiple home runs […]

Read more

The End of Google’s Reign is Near

The end of Google’s reign as the king of search is near. Competitors are eating away market share and growth is sputtering. Trying to cherry-pick the next winner in search, however, is akin to rolling dice at a casino. All luck. Where investors are going to make their millions is in this red hot sector […]

Read more

2 Biotech Candidates with Massive Buyout Potential

One of the big events in the market last week was the over $20 billion purchase of Pharmacyclics (NASDAQ: PCYC) by drug giant AbbVie (NASDAQ: ABBV). The main draw of this company that had a market capitalization of around $4 billion two years ago was its blood cancer drug Imbruvica which posted sales of less […]

Read more

Impending REIT Sell-off Is Great Time to Pick up the Best One out There

I am truly amazed at how the general public invests in the stock market. I think for the great majority, the only two strategies in use are to buy what’s hot or to own the stocks that everyone else owns. There is very little individual stock analysis or comparison shopping. I find this to be […]

Read more

How to Profit from the Rise in Gas Prices

If the price of a gallon of gas by you has jumped close to 50 cents in just a few weeks, then you’ll be happy to know there’s a simple way to profit that any investor can take advantage of. In this article, Tim Plaehn shares his strategy to realize quick share price gains by […]

Read more